Bank of America
PMCB icon

Bank of America’s PharmaCyte Biotech PMCB Stock Holding History

Bank of America’s Portfolio PMCB Stock Details PMCB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-314
Closed -$227 – 6588
2025
Q4 		$227 Sell
314
-224
-42% -$202 ﹤0.01% 6678
2025
Q3 		$522 Sell
538
-4
-0.7% -$4 ﹤0.01% 7582
2025
Q2 		$591 Buy
542
+469
+642% +$523 ﹤0.01% 7636
2025
Q1 		$92 Sell
73
-5
-6% -$8 ﹤0.01% 7847
2024
Q4 		$123 Sell
78
-39
-33% -$67 ﹤0.01% 7695
2024
Q3 		$223 Sell
117
-35
-23% -$65 ﹤0.01% 7541
2024
Q2 		$298 Buy
152
+98
+181% +$211 ﹤0.01% 7470
2024
Q1 		$128 Sell
54
-8
-13% -$17 ﹤0.01% 7379
2023
Q4 		$135 Sell
62
-54
-47% -$117 ﹤0.01% 7383
2023
Q3 		$243 Buy
116
+62
+115% +$158 ﹤0.01% 7391
2023
Q2 		$154 Hold
54
– – ﹤0.01% 7398
2023
Q1 		$157 Sell
54
-44
-45% -$129 ﹤0.01% 7447
2022
Q4 		$286 Buy
98
+44
+81% +$126 ﹤0.01% 7492
2022
Q3 		$0 Sell
54
-1,680
-97% -$4.25K ﹤0.01% 8105
2022
Q2 		$4K Buy
1,734
+1,676
+2,890% +$3.66K ﹤0.01% 7652
2022
Q1 		$0 Hold
58
– – ﹤0.01% 8644
2021
Q4 		$0 Hold
58
– – ﹤0.01% 8543
2021
Q3 		$0 Buy
+58
New +$204 ﹤0.01% 8316

Other funds holding PMCB

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Bank of America's PMCB Position: Q1 2026 in Review

Bank of America sold out of PharmaCyte Biotech (PMCB) in Q1 2026, closing a stake of 314 shares — an estimated $227 sold.

Bank of America first reported a position in PMCB in Q3 2021 and held it in 18 quarters. The position peaked at $4K in Q2 2022. 32 funds tracked by Wall St. Rank hold PMCB as of Q1 2026.

  • Bank of America reported no remaining PharmaCyte Biotech position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 314 PharmaCyte Biotech shares in Q1 2026, an estimated $227.
  • Bank of America first reported a position in PharmaCyte Biotech in Q3 2021 and held it in 18 quarters.
  • Bank of America's PharmaCyte Biotech position peaked at $4K in Q2 2022.
  • 32 funds tracked by Wall St. Rank held PharmaCyte Biotech as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.